Miltenyi Biotec CliniMacs Instrument Cell Separation System, 100V-240V, 2018
Miltenyi Biotec
Details
-
CategoryClinical
-
Dimension24.0in x 28.0in x 35.0in
-
Serial001269
-
Shipping TypeFedEx Ground
-
Manufacturing2018-07-01
-
Voltage / Hertz100V-240V / 50Hz/60Hz
Description
The Miltenyi Biotec CliniMACS Instrument, model number 44085, is a sophisticated cell separation system engineered for efficient and reliable operation in laboratory settings. Manufactured in 2018, it supports a voltage range of 100V-240V and frequency settings of 50Hz/60Hz, enhancing its compatibility across various labs. Despite some cosmetic blemishes typical from normal use, this unit has undergone basic power and test checks, indicating no known functional issues. Built in the United States, the CliniMACS helps streamline complex cell separation procedures, ensuring high-throughput and precision results. Note that this system does not include a computer, software, or additional data cables, but it comes with a power cord for immediate setup. Its durable design underlines its reliability for demanding laboratory workflows.
Key Features
- Efficient cell separation technology
- Compatible with 100V-240V and 50Hz/60Hz
- Tested functional with minor cosmetic wear
- Manufactured in 2018 for reliable performance
- Built in the United States
Specifications
- Brand/Manufacturer: Miltenyi Biotec
- Model: CliniMacs Instrument, Ref: 151-01
- Condition: Good, minor cosmetic wear
- Voltage: 100V-240V
- Frequency: 50Hz/60Hz
- Manufacture Date: July 1, 2018
- Dimensions: 24.0 x 28.0 x 35.0 inches (60.96 x 71.12 x 88.90 cm)
- Weight: 80 lbs (36.29 kg)
Weight
Imperial: 96.0 Pounds
Metric: 43.54 Kilograms
Shipping Dimensions
Imperial: 28.8 lb x 33.6 lb x 42.0 lb
Metric: 73.15 cm x 85.34 cm x 106.68 cm
Harmonized Code
9018.90
Harmonized Code Details
9018.90 - Instruments and appliances used in medical, surgical, dental or veterinary sciences. This code is suitable for the CliniMACS Instrument due to its use in precision cell separation in laboratory environments.
Comments 0
There are currently no public comments.